Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐o...
Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle
About this item
Full title
Author / Creator
Hamed, Mostafa M. , Abdelsamie, Ahmed S. , Rox, Katharina , Schütz, Christian , Kany, Andreas M. , Röhrig, Teresa , Schmelz, Stefan , Blankenfeldt, Wulf , Arce‐Rodriguez, Alejandro , Borrero‐de Acuña, José Manuel , Jahn, Dieter , Rademacher, Jessica , Ringshausen, Felix C. , Cramer, Nina , Tümmler, Burkhard , Hirsch, Anna K. H. , Hartmann, Rolf W. and Empting, Martin
Publisher
Germany: John Wiley & Sons, Inc
Journal title
Language
English
Formats
Publication information
Publisher
Germany: John Wiley & Sons, Inc
Subjects
More information
Scope and Contents
Contents
Pseudomonas aeruginosa (PA) is an opportunistic human pathogen, which is involved in a wide range of dangerous infections. It develops alarming resistances toward antibiotic treatment. Therefore, alternative strategies, which suppress pathogenicity or synergize with antibiotic treatments are in great need to combat these infections more effectively...
Alternative Titles
Full title
Towards Translation of PqsR Inverse Agonists: From In Vitro Efficacy Optimization to In Vivo Proof‐of‐Principle
Authors, Artists and Contributors
Author / Creator
Abdelsamie, Ahmed S.
Rox, Katharina
Schütz, Christian
Kany, Andreas M.
Röhrig, Teresa
Schmelz, Stefan
Blankenfeldt, Wulf
Arce‐Rodriguez, Alejandro
Borrero‐de Acuña, José Manuel
Jahn, Dieter
Rademacher, Jessica
Ringshausen, Felix C.
Cramer, Nina
Tümmler, Burkhard
Hirsch, Anna K. H.
Hartmann, Rolf W.
Empting, Martin
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9929129
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_9929129
Other Identifiers
ISSN
2198-3844
E-ISSN
2198-3844
DOI
10.1002/advs.202204443
